BUEEquity · News and Sentiment
GILD
Gilead Sciences, Inc.
- Latest week
- 21 Aug 2026
- Weekly close
- 58,150.00 ARS
- Fair value
- 33,198.21 ARS
Seven-day news read · 22–28 August 2026
Recent company news leans constructive
Positive company coverage has outnumbered negative coverage across the last seven days.
Company-specific coverage
The news behind the seven-day read
Newest first. The seven-day balance describes these headlines; the weighted score uses a longer 30-day evidence window.
- Investing.com España · Main companyDirector de Gilead Sciences Welters vende acciones por 2,68 millones de dólares
- finance.yahoo.com · Main companyGilead (GILD) Stock Looks Undervalued After A 147% Five Year Run
- finance.yahoo.com · Main companyGilead Sciences (GILD) Wins EU Trodelvy Approval, Is The Stock Fully Priced?
- finance.yahoo.com · Main companyWhat Does Gilead Sciences (GILD) Gain From Its Expanded EU Breast Cancer Approval?
- finance.yahoo.com · Main companyGilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences
- finance.yahoo.com · Main companyGilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting
- finance.yahoo.com · Main companyGilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?
Keep the two readings separate
Recent news shows what changed; the score shows the wider tone
A simple description of company headlines published during 22–28 August 2026.
A 30-day reading that gives more weight to newer, directly relevant coverage.